Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results - Year Ended 31 October 2015

28 Jan 2016 07:01

RNS Number : 2342N
Arden Partners plc
28 January 2016
 

 

Arden Partners plc

("Arden" or the "Group")

 

Results for the year ended 31 October 2015

 

Arden Partners plc (AIM: ARDN), the institutional stockbroking company, today announces results for the year ended 31 October 2015.

 

Financial highlights

 

· Revenue £5.5 million (2014: £8.0 million)

· (Loss)/profit before tax (£2.1) million (2014: £0.08 million)

· Underlying (loss)/profit before tax* (£1.8) million (2014: £0.15million)

· Basic (loss)/earnings per share (10.8p) (2014: 0.5p)

· Capital adequacy ratio 392% (2014: 445%)

 

* Profit before tax as adjusted for the effect of share based payments and reorganisation costs

 

Operational highlights

 

· Luke Johnson appointed to the Board, as a Non-Executive Director, April 2015

· Funds raised for clients £44m

· Retained corporate clients 42

 

Commenting on the results and Arden's outlook, Peter Moon, Chairman, said:

 

"Although Arden has struggled to capitalise on its strong institutional and corporate client base to increase market share in these challenging times, the book of mandated business since the year end has increased substantially and we are confident that work in progress will be converted to profitable business as the year progresses".

 

Arden Partners plc 020 7614 5900

James Reed-Daunter - Chief Executive Officer

Steve Wassell - Chief Operating Officer

 

Altium 020 7484 4040

Sam Fuller

 

 

 

 

Chairman's Statement

 

The trading environment continues to be extremely difficult.

 

Secular forces continue to reduce income from secondary trading and therefore place a greater emphasis on primary and corporate deals as drivers of profitability. We are continuing to position ourselves to take on this changing landscape.

 

Arden has struggled to capitalise on its strong institutional and corporate client base to increase market share in these challenging times. Additionally, industry reorganisation and restructuring has proceeded at a slower pace than we would have expected which has resulted in sub-standard returns across the sector.

 

Whilst this is not a time to be complacent, Arden's strong balance sheet puts us in a good position to continue making necessary changes to our model, thus allowing the firm to generate shareholder returns in the long term.

 

The board and management are determined to make the changes required to put Arden in a favourable position to take advantage of future opportunities.

 

Since the year end the book of mandated business has increased substantially and one high profile transaction has been completed. We are confident that work in progress will be converted to profitable business as the year progresses.

 

Given the calibre of the staff we have and their commitment to achieving results I am sure that Arden has a long and successful future ahead of it and thank everyone for their contributions in the past year.

 

I will be stepping down as a director and Chairman of Arden at the next AGM after five years on the board and Luke Johnson will take on the role. It has been an enjoyable, testing but stimulating period during which I have received strong support from the entire team at Arden, I thank them warmly for that and wish them and the company every good fortune in the future.

 

Peter Moon

Chairman

 

 

 

Chief Executive's Statement

 

After a slower than expected first half, as referred to in my interim statement, the encouraging start to the second half failed to maintain momentum which in turn has led to a disappointing out-turn for the full year.

 

However, Arden continues to be managed tightly and we continue to make the changes necessary to adapt to evolving market conditions.

 

2015 has continued to see investment in personnel to further strengthen our product offering and client service. The team is focussed to maximise revenues in traditional areas, but also to add other growth sectors to our portfolio.

 

Financial Review

Revenue in the year ended 31 October 2015 was £5.5m compared to £8.0m in 2014. The underlying loss before taxation, which is stated before charging share-based payments and reorganisation costs, was £1.8m and compares to a profit before taxation in 2014, of £0.15m.

 

The basic loss per share was 10.8p compared to earnings per share of 0.5p in 2014.

 

The Board has continued its programme of buying back the Company's shares in order to enhance shareholder value, under the authority granted by the Shareholders. During the year ended 31 October 2015, the Company purchased 2,425,019 ordinary shares for a consideration of £1.1m. Of these purchases 2,330,130 shares were cancelled and the total share capital reduced accordingly.

 

At the financial year end the Company held 455,976 ordinary shares of 10 pence each in Treasury. The total cost of these shares was £0.3m.

 

Outlook

Although market conditions continue to be challenging, with volatile global markets and commodity concerns in 2016, continuing the trends of the latter months of 2015, Arden has already booked a number of transactions in its new financial year and is working to complete further mandates from its healthy pipeline of corporate business.

 

With a strong balance sheet and a strong Board we continue to work hard to deliver shareholder value for the longer term.

 

Finally, I would like to take this opportunity to thank our staff for their commitment through a challenging period.

 

James Reed-Daunter

Chief Executive Officer

 

 

 

 

Consolidated Statement of Comprehensive Income

For the year ended 31 October 2015

 

 

2015

2014

 

Note

£'000

£'000

Revenue

2

5,486

7,955

Administrative expenses

 

(7,646)

(7,936)

(Loss)/profit from operations

 

(2,160)

19

Finance income

 

65

61

Finance expense

 

(2)

(5)

(Loss)/profit before taxation

 

(2,097)

75

Income tax credit

 

-

40

(Loss)/profit after taxation

 

(2,097)

115

Other comprehensive income for the year:

Items that will or may be reclassified subsequently to profit or loss:

  Decrease in fair value of available for sale financial assets

 

 

 

 

(7)

 

 

 

(12)

Deferred tax taken to equity

 

6

-

Total comprehensive income for the year attributable to equity shareholders

 

(2,098)

103

 

 

 

 

 

(Loss)/earnings per share

 

 

 

Basic

3

(10.8p)

0.5p

Diluted

3

(10.8p)

0.5p

 

 

 

 

Consolidated Statement of Financial Position

At 31 October 2015

 

 

 

 

 

 

 

 

2015

2015

2014

2014

 

Note

£'000

£'000

£'000

£'000

Assets

 

 

 

 

 

Non-current assets

 

 

 

 

 

Property, plant and equipment

 

 

25

 

43

Deferred tax asset

 

 

84

 

86

Total non-current assets

 

 

109

 

129

Current assets

 

 

 

 

 

Assets held at fair value

 

1,703

 

2,350

 

Available for sale financial assets

 

507

 

467

 

Trade and other receivables

 

2,138

 

4,770

 

Stock borrowing collateral

 

120

 

102

 

Cash and cash equivalents

 

5,372

 

8,282

 

Corporation tax asset

 

16

 

8

 

Total current assets

 

 

9,856

 

15,979

Total assets

 

 

9,965

 

16,108

Current liabilities

 

 

 

 

 

Financial liabilities held at fair value

 

(92)

 

(75)

 

Trade and other payables

 

(1,979)

 

(4,886)

 

Total current liabilities

 

 

(2,071)

 

(4,961)

Total liabilities

 

 

(2,071)

 

(4,961)

Net assets

 

 

7,894

 

11,147

        

 

Shareholders' equity

 

 

 

 

 

Called up share capital

 

 

2,063

 

2,296

Capital redemption reserve

 

 

700

 

467

Share premium account

 

 

2,933

 

2,933

Employee Benefit Trust reserve

 

 

(849)

 

(849)

Available for sale reserve

 

 

(6)

 

(33)

Retained earnings

 

 

3,348

 

6,597

Total equity before deduction of own shares

 

 

8,189

 

11,411

Own shares

 

 

(295)

 

(264)

Total equity

 

 

7,894

 

11,147

 

 

 

 

Consolidated Statement of Cash Flows

For the year ended 31 October 2015

 

 

2015

2014

 

 

£'000

£'000

Operating activities before taxation

 

 

 

(Loss)/profit before tax

 

(2,097)

75

Adjustments for:

 

 

 

Fair value adjustments of derivative financial assets

 

287

538

Depreciation of fixtures, fittings and computer equipment

 

25

82

Net interest receivable

 

(63)

(57)

Share based payments

 

111

77

Operating cash flow before changes in working capital

 

(1,737)

715

Decrease in operating assets

 

2,976

18,673

Decrease in operating liabilities

 

(2,892)

(14,111)

Purchase of available for sale investments

 

(513)

-

Proceeds from disposal of available for sale investments

 

466

-

Cash generated from operations

 

(1,700)

5,277

Income taxes paid

 

-

(286)

Net cash flows from operating activities

 

(1,700)

4,991

Investing activities

 

 

 

Purchases of property, plant and equipment

 

(7)

(33)

Net interest received

 

63

57

Net cash flows from investing activities

 

56

24

Financing activities

 

 

 

Proceeds from the sale of own shares

 

10

222

Purchase of own shares

 

(1,136)

(322)

Dividends paid to equity shareholders

 

(140)

(366)

Net cash flows from financing activities

 

(1,266)

(466)

(Decrease)/increase in cash and cash equivalents

 

(2,910)

4,549

Cash and cash equivalents at the beginning of the year

 

8,282

3,733

Cash and cash equivalents at the end of the year

 

5,372

8,282

 

 

 

 

Consolidated Statement of Changes in Equity

For the year ended 31 October 2015

 

 

Share

capital

Share

Premium

account

 

 

Capital Redemption Reserve

 

 

 

Own

shares

Employee

Benefit Trust

Reserve

 

 

Available

 for sale

 Reserve

Retained

earnings

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Balance at

1 November 2013

2,296

2,933

467

-

(1,046)

(21)

6,804

11,433

Profit for year

-

-

-

-

-

-

115

115

Revaluation of available for sale financial assets

-

-

-

-

-

(12)

-

(12)

Total comprehensive income for the year

-

-

-

-

-

(12)

115

103

Contributions by and distributions to owners

 

 

 

 

 

 

 

 

Purchase of own shares

-

-

-

(322)

-

-

-

(322)

Sale of own shares

-

-

-

58

-

-

-

58

Share based payments

-

-

-

-

-

-

77

77

Sale of shares by Employee Benefit Trust to satisfy employee share schemes

-

-

-

-

197

-

(33)

164

Dividends paid to equity shareholders

-

-

-

-

-

-

(366)

(366)

Balance at

31 October 2014

2,296

2,933

467

(264)

(849)

(33)

6,597

11,147

Profit for year

-

-

-

-

-

-

(2,097)

(2,097)

Deferred tax taken to equity

-

-

-

-

-

-

6

6

Revaluation of available for sale financial assets

-

-

-

-

-

(7)

-

(7)

Transferred to retained earnings on disposal of available for sale assets

-

-

-

-

-

34

(34)

-

Total comprehensive income for the year

-

-

-

-

-

27

(2,125)

(2,098)

Contributions by and distributions to owners

 

 

 

 

 

 

 

 

Purchase of own shares

-

-

-

(1,136)

-

-

-

(1,136)

Sale of own shares

-

-

-

10

-

-

-

10

Own shares cancelled

(233)

-

233

1,095

-

-

(1,095)

-

Share based payments

-

-

-

-

-

-

111

111

Dividends paid to equity shareholders

-

-

-

-

-

-

(140)

(140)

Balance at

31 October 2015

2,063

2,933

700

(295)

(849)

(6)

3,348

7,894

 

Notes

1. The capital redemption reserve represents the nominal value of shares that have been cancelled that were previously held as Own Shares.

 

2. Own Shares represents shares purchased to be held as treasury shares at historical cost.

 

3. The Employee Benefit Trust reserve represents shares held in the parent Company by the Arden Partners Employee Benefit Trust which is consolidated in the Group's financial statements.

 

In the prior year 343,168 ordinary shares were issued from the employee benefit trust to satisfy employee share options.

 

 

 

 

NOTES

1) Basis of preparation

The financial information set out in this announcement has been prepared in accordance with the recognition and measurement principles of IFRS as endorsed for use in the European Union.

The financial information set out in this announcement does not constitute the Group's statutory accounts for the year ended 31 October 2015 or the year ended 31 October 2014 under the meaning of s434 Companies Act 2006, but is derived from those accounts.

Statutory accounts for the years ended 31 October 2015 and 31 October 2014 have been reported on by the Independent Auditors.

The Independent Auditors' Report on the Annual Report and Financial Statements for the years ended 31 October 2015 and 31 October 2014 was unqualified, did not draw attention to any matters by way of emphasis, and did not contain a statement under 498(2) or 498(3) of the Companies Act 2006.

Statutory accounts for the year ended 31 October 2014 have been filed with the Registrar of Companies. The statutory accounts for the year ended 31 October 2015, prepared under IFRS, will be delivered to the Registrar in due course.

 

2) Revenue

 

Revenue is wholly attributable to the principal activity of the Group and arises solely within the United Kingdom.

 

 

 

2015

2014

 

 

£'000

£'000

Equities Division

 

2,172

2,689

Corporate Finance Division

 

3,314

5,266

Total revenue

 

5,486

7,955

 

Included within revenue of the Equities Division is a loss of £287,000 (2014: loss £538,000) relating to the fair value adjustment of derivatives held within assets that are fair valued through profit or loss.

 

The Directors are of the opinion that there are only two operating segments and while segment revenues are reviewed internally business resources are not allocated to segments for the purposes of deriving either profit or assets. In 2015 one of the Group's customers contributed more than 10% of the Group's revenue, the amount was £914,000. In 2014 none of the Group's customers contributed 10% or more of the Group's revenue.

 

3) Earnings per Share

 

In addition to the basic earnings per share, underlying earnings per share has been shown because the Directors consider that this gives a more meaningful indication of the underlying performance of the Group. Where applicable, all adjustments are stated after taking into consideration current tax treatment ignoring deferred tax.

 

 

Year ended

31 October 2015

Year ended

31 October 2014

 

Pence per

Share

Numerator

£'000

Pence per

Share

Numerator

£'000

Basic (loss)/earnings per share

(10.8)

(2,097)

0.5

115

Add: IFRS2 share-based payments

0.5

111

0.4

77

Add: Reorganisation payments

0.9

177

-

-

Underlying basic (loss)/earnings

(9.4)

(1,809)

0.9

192

 

 

 

 

 

Diluted (loss)/earnings per share

(10.8)

(2,097)

0.5

115

Add: IFRS2 share-based payments

0.5

111

0.4

77

Add: Reorganisation payments

0.9

177

-

-

Underlying diluted (loss)/earnings

(9.4)

(1,809)

0.9

192

      

 

 

Year ended

31 October 2015

 

Year ended

31 October 2014

 

 

Number

 

Number

 

Denominator

 

 

 

 

Weighted average number of shares in issue for basic earnings calculation

19,282,644

 

20,818,253

 

Weighted average dilution for outstanding share options

840,385

 

1,132,883

 

Weighted average number for diluted earnings calculation

20,123,029

 

21,951,136

 

 

 

 

 

 

 

The 1,480,700 (2014: 1,480,700) shares held by the Arden Partners Employee Benefit and the 455,976 (2014: 461,087) shares held in Treasury have been excluded from the denominator.

 

No adjustment has been made to the diluted loss per share of 10.4p as the dilution effect of the weighted average number of outstanding share options of 840,385 would be to decrease the loss per share.

 

4) Annual Report and Accounts

 

Copies of the 2015 Report and Accounts will be posted to shareholders in due course. Copies will also be available from the Company's registered office and from the Company's website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR DDGDBBGDBGLR
Date   Source Headline
28th Apr 202210:15 amRNSOffer Update - Scheme of Arrangement - Effective
28th Apr 20227:30 amRNSSuspension - Arden Partners PLC
28th Apr 20227:00 amRNSNomad register change - Arden Partners Plc
27th Apr 20224:30 pmRNSOffer Update-Court Sanction, Scheme of Arrangement
27th Apr 20224:30 pmRNSOffer Update - Court Sanction of Scheme
21st Apr 20225:30 pmRNSInce Group
19th Apr 20222:00 pmRNSOffer Update – Extension of FCA approval
19th Apr 20222:00 pmRNSExtension of FCA Change of Control Approval
14th Apr 20227:00 amRNSOffer Update - Timetable for completion of Scheme
14th Apr 20227:00 amRNSOffer Update - Timetable for Completion of Scheme
12th Apr 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20227:00 amRNSOffer update – Waiver of NOMAD condition
11th Apr 20227:00 amRNSOffer Update - Waiver of NOMAD Condition
8th Apr 20222:19 pmRNSPublication of Annual Report and Notice of AGM
7th Apr 20222:18 pmRNSHolding(s) in Company
7th Apr 20229:33 amRNSUpdate regarding the NOMAD condition
7th Apr 20227:00 amRNSUpdate Regarding the Nomad Condition
6th Apr 202211:41 amRNSForm 8.3 - Arden Partners plc
5th Apr 20227:00 amRNSAudited Results for the Year Ended 31 October 2021
18th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI) - AssetCo PLC
14th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202210:20 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:48 amRNSForm 8.3 - Ince Group PLC
7th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 20221:03 pmRNSForm 8.5 (EPT/NON-RI)
2nd Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20221:00 pmRNSForm 8.5 (EPT/NON-RI)
26th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20227:00 amRNSApproval of the FCA condition
21st Jan 20227:00 amRNSFCA Approval of the Change of Control
20th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20224:30 pmRNSResults of Arden court meeting & general meeting
19th Jan 20224:24 pmRNSResults of Court Meeting and General Meeting
18th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20212:30 pmRNSPublication of Scheme Document
15th Dec 20217:00 amRNSExtension Of Irrevocable Undertakings
8th Dec 20218:00 amRNSExtension Of Irrevocable Undertakings
1st Dec 20212:03 pmRNSForm 8 (DD) - The Ince Group plc
30th Nov 202111:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.